This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks associated with…
Reuters Health Information